High Throughput Hematological Analysis Platform Receives FDA Clearance
Scopio Labs’ X100HT device with Peripheral Blood Smear (PBS) Application for hematological analysis has received U.S. FDA 510(k) clearance.
Read MorePosted by Chris Wolski | Jun 10, 2022 | Microscopy |
Scopio Labs’ X100HT device with Peripheral Blood Smear (PBS) Application for hematological analysis has received U.S. FDA 510(k) clearance.
Read MorePosted by Andy Lundin | Jun 6, 2022 | Lung Cancer |
A simple blood test could be an ideal predictor of whether cancer immunotherapy will be successful for a lung cancer patient.
Read MorePosted by Chris Wolski | May 26, 2022 | Cancer |
Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients.
Read MorePosted by Chris Wolski | May 11, 2022 | Lab Management |
Laboratory leadership needs to develop coherent succession planning to allow for the continuity of laboratory operations.
Read MorePosted by Andy Lundin | May 6, 2022 | Hematology & Serology, Molecular Diagnostics |
Researchers have developed an approach to identify blood biomarkers that could predict the suicide risk of major depressive disorder patients.
Read More